The Modifier 25, upcoding, and Medicare billing patterns that signal fraud, and the gap between the chart and the claim where the case is made.
Most healthcare fraud cases turn on a gap between two documents: what the medical record shows was done, and what the claim billed for. The trouble is that most reviewers only read one side. A coding auditor can read the claims data but not the clinical picture. A nurse reviewer can read the chart but not the billing. I read both.
I'm a master's-prepared registered nurse and legal nurse consultant who reviews medical records alongside claims and billing data to find where the care delivered and the care billed do not match. For a False Claims Act, qui tam, or Medicare fraud matter, that combined view is often where the case is made.
Connecting clinical care to coding accuracy is the core of what I do, and it's rare. A CPT or evaluation-and-management code is a claim about what happened to a patient. Verifying that claim means reading the record the way a nurse reads it, understanding what the documentation actually supports, and comparing that to what was submitted. Someone who only knows codes can tell you a modifier was appended; they can't always tell you whether the underlying care justified it. I can speak to both, and explain the difference in terms a jury or a reviewing attorney can follow.
Common patterns I analyze in healthcare billing fraud matters include:
I have served as a behind-the-scenes consulting reviewer, analyzing medical records and billing, in resolved federal False Claims Act matters, including:
Ophthalmic Consultants of Boston — resolved for approximately $3.9 million over allegations that the practice used Modifier 25 to bill Medicare and MassHealth for office visits alongside intravitreal eye injections without documentation supporting a separate service. DOJ announcement.
Massachusetts Eye and Ear — resolved for $2,678,013 over allegations that it used Modifier 25 to bill Medicare and MassHealth for office visits alongside nasal endoscopies and laryngoscopies when a significant, separately identifiable evaluation and management service was not performed. DOJ settlement agreement.
Fresenius Medical Care — the largest operator of kidney dialysis clinics in the United States, resolved for $5.2 million over allegations that it billed Medicare for medically unnecessary Hepatitis B testing of dialysis patients. DOJ announcement.
Dialysis is one of the most heavily billed and closely scrutinized areas of Medicare, and it's an area I know from the inside, having worked in dialysis before I ever reviewed a record for an attorney. That combination, clinical dialysis experience plus billing-fraud review, is unusual, and it's directly relevant to Medicare fraud matters involving end-stage renal disease care, as the Fresenius matter above reflects.
I start with the medical record and the corresponding billing or claims data side by side, and work through where they diverge. From there I document the specific discrepancies, tie each one to the underlying documentation, and produce findings an attorney can use to evaluate the case or support a filing. My goal is to give you a clear, defensible picture of where the billing departs from the care the record actually supports.
Master's-prepared registered nurse with clinical experience across dialysis, ICU, and other hospital settings, and years of legal nurse consulting focused on medical record review, including healthcare billing and coding analysis for fraud matters.
Have a healthcare fraud case that needs a nurse's eyes on both the chart and the billing? Email me for a case consult at info@ChambersMLC.com.